KMTS Kestra Medical Technologies, Ltd.

NASDAQ
$27.14

Kestra Medical Technologies, Ltd. (KMTS) is expected to report earnings on December 14, 2026, after the market close. The consensus earnings estimate is a loss of $0.61 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +23.9% since its last earnings release on September 14, 2026.

Kestra Medical Technologies, Missed Consensus Estimates, Raises Guidance
Monday, September 14, 2026 · 4:01 PM ET
Earnings Date
2nd Quarter, Oct 2026
Dec 14
Monday · 4:00 PM ET
Earnings Whisper
-
vs ($0.61)
Rev est $31.54M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $24.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.